Arete Wealth Advisors’s British American Tobacco BTI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-5,640
Closed -$299K 412
2025
Q3
$299K Sell
5,640
-1,163
-17% -$63.1K 0.02% 605
2025
Q2
$322K Buy
6,803
+539
+9% +$23.9K 0.02% 535
2025
Q1
$259K Sell
6,264
-113
-2% -$4.44K 0.02% 586
2024
Q4
$231K Buy
6,377
+93
+1% +$3.36K 0.02% 649
2024
Q3
$229K Sell
6,284
-1,251
-17% -$44.7K 0.02% 609
2024
Q2
$232K Sell
7,535
-4,041
-35% -$123K 0.02% 614
2024
Q1
$353K Buy
11,576
+4,071
+54% +$123K 0.03% 327
2023
Q4
$220K Sell
7,505
-1,529
-17% -$46.5K 0.02% 648
2023
Q3
$284K Buy
+9,034
New +$298K 0.05% 356

Other funds holding BTI

Arete Wealth Advisors's BTI Position: Q4 2025 in Review

Arete Wealth Advisors sold out of British American Tobacco (BTI) in Q4 2025, closing a stake of 5,640 shares — an estimated $299K sold.

Arete Wealth Advisors first reported a position in BTI in Q3 2023 and held it in 9 quarters. The position peaked at $353K in Q1 2024. 823 funds tracked by Wall St. Rank hold BTI as of Q4 2025.

  • Arete Wealth Advisors reported no remaining British American Tobacco position as of Q4 2025 after selling out during the quarter.
  • Arete Wealth Advisors sold 5,640 British American Tobacco shares in Q4 2025, an estimated $299K.
  • Arete Wealth Advisors first reported a position in British American Tobacco in Q3 2023 and held it in 9 quarters.
  • Arete Wealth Advisors's British American Tobacco position peaked at $353K in Q1 2024.
  • 823 funds tracked by Wall St. Rank held British American Tobacco as of Q4 2025.

Based on Arete Wealth Advisors's 13F filing for Q4 2025, filed 13 Feb 2026.